M E Rosenthale, A A Santilli, A C Scotese, S C Bell, B A Rubin
Wyeth Labs Inc., Radnor, Pennsylvania 19087.
Journal of immunopharmacology 1980When tested in a series of immunopharmacologic assays, the interferon inducer, WY-15297, was shown to lack activity in early vascular and humoral phases of the inflammatory response, while it was quite effective against the immunologic phase. The profile of activity of Wy-15927 was, however, unlike those previously described for reference antiinflammatory and immunosuppressive drugs and this may represent one of a new class of immunopharmacologic agents capable of selectively modulating the lymphoreticular system.
M E Rosenthale, A A Santilli, A C Scotese, S C Bell, B A Rubin. Immunopharmacologic properties of 1,6-bis[2-(diethylamino)ethoxy]xanthen-9-one dihydrochloride (Wy-15297). Journal of immunopharmacology. 1980;2(2):257-77
PMID: 6821553
View Full Text